Trial Summary
What is the purpose of this trial?
This trial is testing WATChmAN, an online system for testicular cancer patients to manage their follow-up care virtually. It aims to make follow-ups easier and more convenient by reducing the need for regular hospital visits. Patients will receive reminders, check their results, and communicate with doctors through the platform.
Eligibility Criteria
This trial is for men over 18 who can understand English, have access to a digital device, and have had stage 1 testicular cancer treated with orchiectomy within the last 9 months. They should be ready to follow a strict check-up schedule. Men with metastatic disease or relapse in the first 9 months, or poor computer skills as judged by the study team cannot join.Inclusion Criteria
I had surgery to remove a testicle due to cancer and am being closely monitored.
I am a man aged 18 or older.
Can read, write, and speak English
See 3 more
Exclusion Criteria
My cancer spread or came back within 9 months of starting active surveillance.
The study team considers my computer skills or ability to follow the study plan as inadequate.
Treatment Details
Interventions
- WATChmAN Virtual Testicular Cancer Clinic (Behavioural Intervention)
Trial OverviewThe WATChmAN project is testing a web-based virtual clinic against traditional in-person visits for monitoring testicular cancer patients under active surveillance. The goal is to see if online follow-ups can improve patient satisfaction and adherence while reducing costs.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: WATChmANExperimental Treatment1 Intervention
Patients randomized to the WATChmAN Active Surveillance arm will receive their active surveillance testicular cancer care via an online virtual clinic. Importantly, patients will follow the same surveillance schedule as patients in the standard of care arm. However, patients in the WATChmAN arm will be able to see their upcoming tests and virtual appointments online, request requisitions to perform their required testing at outside institutions, and indicate any concerns for physicians to review during the virtual visit.
Group II: Standard of CareActive Control1 Intervention
Patients randomized to the standard of care arm (in-person active surveillance) will follow the current active surveillance protocol in place at Princess Margaret Cancer Centre's Multidisciplinary Testicular Cancer Clinic. This protocol involves the same schedule of testing as the WATChmAN arm, but will require patients to come into the clinic to receive their test results (as in current practice).
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Princess Margaret Cancer CentreToronto, Canada
Loading ...
Who Is Running the Clinical Trial?
University Health Network, TorontoLead Sponsor